Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranolazine Effects on Ischemic Mitral Regurgitation Severity in Patients With Cardiac Resynchronization Therapy

NCT01979965 is registered in ClinicalTrials.gov with University Cardiology as lead sponsor.

NCT NCT01979965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01979965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranolazine Effects on Ischemic Mitral Regurgitation Severity in Patients With Cardiac Resynchronization Therapy
Lead sponsor
University Cardiology
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2013
Completion date
September 30, 2014
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic mitral regurgitation